Document is current
Any future updates will be listed below
-
Authors
Kerr, Caroline P. https://orcid.org/0000-0002-2389-9229
Jin, Won Jong https://orcid.org/0000-0003-4147-9735
Liu, Peng
Grudzinski, Joseph J.
Ferreira, Carolina A.
Comas Rojas, Hansel https://orcid.org/0009-0007-4933-6428
Oñate, Alejandro J.
Kwon, Ohyun https://orcid.org/0000-0002-0334-105X
Hyun, Meredith
Bio Idrissou, Malick https://orcid.org/0009-0001-0437-6668
Welch Schwartz, René
Vera, Jessica M. https://orcid.org/0000-0001-7411-8501
Clark, Paul A. https://orcid.org/0000-0002-1608-1146
Adeniyi, Adedamola
Takashima, Maya https://orcid.org/0009-0003-9561-9032
Erbe, Amy K. https://orcid.org/0000-0003-1175-4062
Shea, Amanda G. https://orcid.org/0009-0009-5491-0214
Powers, Maria
Pinchuk, Anatoly N.
Massey, Christopher F. https://orcid.org/0000-0001-9321-1955
Choi, Cynthia
Hernandez, Reinier
Bednarz, Bryan P.
Ong, Irene M. https://orcid.org/0000-0002-9353-6941
Weichert, Jamey P.
Morris, Zachary S. https://orcid.org/0000-0001-5558-3547
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (P50CA278595, P01CA250972, P50DE026787, P30CA014520, S10OD028670-01, F30CA268780, T32GM140935)
- License Information
-
More Information
Article History
Received: 26 December 2024
Accepted: 13 January 2026
First Online: 26 January 2026
Competing interests
: J.J.G. is cofounder and Chief Innovation Officer of Voximetry, Inc. H.C.R. provides consulting services to Archeus Technologies, which holds the license rights to NM600 related technologies. O.K. provides consulting services to Voximetry, Inc. R.H. is a member of the scientific advisory board for Archeus Technologies. B.P.B. is cofounder and Chief Science Officer of Voximetry, Inc. J.P.W. is a founder and Chief Science Advisor for Archeus Technologies. Z.S.M. has served as a member of the scientific advisory board for Seneca Therapeutics, Archeus Technologies, NorthStar Medical Radioisotopes, and Cali Biomedical, as a consultant for Johnson and Johnson and Telix Pharmaceuticals, and has sponsored research agreements with Point Biopharmaceuticals and Telix Pharmaceuticals. Z.S.M. has received material support for research (drug reagents) from Bayer Pharmaceuticals, B.M.S., XRD therapeutics, Seneca Therapeutics, AstraZeneca, HiberCell, Apeiron, Nektar Therapeutics, and Invenra. R.H., J.P.W., and Z.S.M. are inventors on patents held by the University of Wisconsin Alumni Research Foundation related to select radiopharmaceutical therapies and the interaction of radiopharmaceutical therapies with immunotherapies. All other authors declare they have no competing interests.
